<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: The aim of our study was to evaluate the relationship between left ventricular (LV) dyssynchrony and the risk of <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> (VT) or <z:hpo ids='HP_0001663'>ventricular fibrillation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>) in patients enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy) trial </plain></SENT>
<SENT sid="1" pm="."><plain>BACKGROUND: Intraventricular mechanical dyssynchrony might be an important factor in ventricular arrhythmogenesis by enhancing electrical <z:hpo ids='HP_0001425'>heterogeneity</z:hpo> in <z:hpo ids='HP_0001635'>heart failure</z:hpo> patients </plain></SENT>
<SENT sid="2" pm="."><plain>The effects of dyssynchrony have not yet been evaluated in a large cohort of implantable cardioverter-defibrillator (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e>) and cardiac resynchronization therapy with defibrillator (CRT-D) patients </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: LV dyssynchrony was measured at baseline and at 12-months by speckle-tracking echocardiography, defined as the standard deviation of time to peak systolic strain in 12 LV myocardial segments </plain></SENT>
<SENT sid="4" pm="."><plain>The endpoint was the first VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>/<z:hpo ids='HP_0011420'>death</z:hpo> or VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>LV dyssynchrony was evaluated in 764 <z:hpo ids='HP_0011713'>left bundle branch block</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>) patients and in 312 non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> patients </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: Baseline LV dyssynchrony was not predictive of VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>/<z:hpo ids='HP_0011420'>death</z:hpo> or VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> or non-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> patients in either treatment arm </plain></SENT>
<SENT sid="7" pm="."><plain>In CRT-D patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e>, improvement in LV dyssynchrony over a year was associated with significantly lower incidence of VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>/<z:hpo ids='HP_0011420'>death</z:hpo> (p &lt; 0.001) and VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> (p &lt; 0.001) compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients and to CRT-D patients with unchanged or worsening dyssynchrony </plain></SENT>
<SENT sid="8" pm="."><plain>Among <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> patients, 15% decrease in LV dyssynchrony was associated with lower risk of VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>/<z:hpo ids='HP_0011420'>death</z:hpo> (hazard ratio: 0.49, 95% confidence interval: 0.24 to 0.99, p = 0.049) and VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> (hazard ratio: 0.30, 95% confidence interval: 0.12 to 0.77, p = 0.009) as compared to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> patients </plain></SENT>
<SENT sid="9" pm="."><plain>Patients without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> receiving CRT-D did not show reduction in VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>/<z:hpo ids='HP_0011420'>death</z:hpo> or in VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in relation to improving dyssynchrony when evaluating cumulative event rates or risk of events </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Baseline LV dyssynchrony did not predict VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e>/<z:hpo ids='HP_0011420'>death</z:hpo> or VT/<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">VF</z:e> in mild <z:hpo ids='HP_0001635'>heart failure</z:hpo> patients with or without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>CRT-induced improvement of LV dyssynchrony was associated with significant reduction of <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> in patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">LBBB</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>(Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy [MADIT-CRT]; NCT00180271) </plain></SENT>
</text></document>